{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:22:03Z","timestamp":1787851323943,"version":"build-2784847793"},"reference-count":26,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["824B2004"],"award-info":[{"award-number":["824B2004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82341211"],"award-info":[{"award-number":["82341211"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270218"],"award-info":[{"award-number":["82270218"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A20291"],"award-info":[{"award-number":["U22A20291"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017413","name":"Innovation Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2022-I2M-1-022"],"award-info":[{"award-number":["2022-I2M-1-022"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2023-I2M-2-007"],"award-info":[{"award-number":["2023-I2M-2-007"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.esmoop.2026.108339","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T21:27:23Z","timestamp":1785533243000},"page":"108339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["MYC rearrangement improves the predictive efficacy of the double-hit model in newly diagnosed multiple myeloma"],"prefix":"10.1016","volume":"11","author":[{"given":"J.","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.esmoop.2026.108339_bib1","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/leu.2017.179","article-title":"Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients","volume":"32","author":"Shah","year":"2018","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.esmoop.2026.108339_bib2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.mayocp.2013.01.019","article-title":"Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013","volume":"88","author":"Mikhael","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.esmoop.2026.108339_bib3","article-title":"Experts\u2019 consensus on the definition and management of high risk multiple myeloma","volume":"12","author":"Marcon","year":"2022","journal-title":"Front Oncol"},{"issue":"24","key":"10.1016\/j.esmoop.2026.108339_bib4","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1200\/JCO-24-01893","article-title":"International Myeloma Society\/International Myeloma Working Group consensus recommendations on the definition of high-risk multiple myeloma","volume":"43","author":"Avet-Loiseau","year":"2025","journal-title":"J Clin Oncol"},{"issue":"24","key":"10.1016\/j.esmoop.2026.108339_bib5","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1200\/JCO-24-01253","article-title":"Co-occurrence of cytogenetic abnormalities and high-risk disease in newly diagnosed and relapsed\/refractory multiple myeloma","volume":"43","author":"Kaiser","year":"2025","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.esmoop.2026.108339_bib6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41408-019-0255-z","article-title":"Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma","volume":"9","author":"Smadbeck","year":"2019","journal-title":"Blood Cancer J"},{"issue":"19","key":"10.1016\/j.esmoop.2026.108339_bib7","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.1158\/1078-0432.CCR-21-0005","article-title":"The prognostic role of MYC structural variants identified by NGS and FISH in multiple myeloma","volume":"27","author":"Sharma","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"24","key":"10.1016\/j.esmoop.2026.108339_bib8","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1158\/1078-0432.CCR-20-2283","article-title":"Implications of MYC rearrangements in newly diagnosed multiple myeloma","volume":"26","author":"Abdallah","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.esmoop.2026.108339_bib9","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1182\/blood-2006-08-040410","article-title":"Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du My\u00e9lome","volume":"109","author":"Avet-Loiseau","year":"2007","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.esmoop.2026.108339_bib10","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.3324\/haematol.2011.056176","article-title":"Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders","volume":"97","author":"Ross","year":"2012","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.esmoop.2026.108339_bib11","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1182\/blood.V98.10.3082","article-title":"Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors","volume":"98","author":"Avet-Loiseau","year":"2001","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108339_bib12","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3109\/10428194.2014.924116","article-title":"Chromosome 8q24.1\/c-MYC abnormality: a marker for high-risk myeloma","volume":"56","author":"Glitza","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108339_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2014.13","article-title":"Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients","volume":"4","author":"Walker","year":"2014","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.esmoop.2026.108339_bib14","series-title":"Chromosomal Translocations and Genome Rearrangements in Cancer","first-page":"139","article-title":"Immunoglobulin and MYC rearrangements in multiple myeloma pathogenesis","author":"Bergsagel","year":"2015"},{"key":"10.1016\/j.esmoop.2026.108339_bib15","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1182\/blood.V98.10.3082","article-title":"Intergroupe Francophone du My\u00e9lome. Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors","volume":"10","author":"Avet-Loiseau","year":"2001","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108339_bib16","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.3324\/haematol.2015.136929","article-title":"Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma","volume":"101","author":"Weinhold","year":"2016","journal-title":"Haematologica"},{"issue":"suppl 1","key":"10.1016\/j.esmoop.2026.108339_bib17","article-title":"Comprehensive analysis of MYC translocations in multiple myeloma by whole genome sequencing and whole transcriptome sequencing","volume":"134","author":"Seliger","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.esmoop.2026.108339_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cancergen.2020.01.001","article-title":"The combination of WGS and RNA-Seq is superior to conventional diagnostic tests in multiple myeloma: ready for prime time?","volume":"242","author":"H\u00f6llein","year":"2020","journal-title":"Cancer Genet"},{"issue":"11","key":"10.1016\/j.esmoop.2026.108339_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7194","article-title":"Myc rearrangement redefines the stratification of high-risk multiple myeloma","volume":"13","author":"Jin","year":"2024","journal-title":"Cancer Med"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108339_bib20","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/bjh.15782","article-title":"The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT\/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial","volume":"185","author":"Cook","year":"2019","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108339_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41408-019-0271-z","article-title":"High level MYC amplification in B-cell lymphomas: is it a marker of aggressive disease?","volume":"10","author":"Pophali","year":"2020","journal-title":"Blood Cancer J"},{"issue":"11","key":"10.1016\/j.esmoop.2026.108339_bib22","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1038\/bjc.2014.218","article-title":"Clinicopathologic and prognostic significance of c-MYC copy number gain in lung adenocarcinomas","volume":"110","author":"Seo","year":"2014","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.esmoop.2026.108339_bib23","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/his.14433","article-title":"The impact of MYC gene amplification on the clinicopathological features and prognosis of radiation-associated angiosarcomas of the breast","volume":"79","author":"Kuba","year":"2021","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108339_bib24","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/ejh.13440","article-title":"IgH translocation with undefined partners is associated with superior outcome in multiple myeloma patients","volume":"105","author":"Mao","year":"2020","journal-title":"Eur J Haematol"},{"issue":"25","key":"10.1016\/j.esmoop.2026.108339_bib25","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1200\/JCO.21.01935","article-title":"Daratumumab, carfilzomib, lenalidomide, and dexamethasone with minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma","volume":"40","author":"Costa","year":"2022","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108339_bib26","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1182\/blood.2025029999","article-title":"High-risk genomic consensus validation for patients with newly diagnosed multiple myeloma using next-generation sequencing","volume":"147","author":"Schavgoulidze","year":"2026","journal-title":"Blood"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926022817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926022817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:34:27Z","timestamp":1787848467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702926022817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2059702926022817"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.108339","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MYC rearrangement improves the predictive efficacy of the double-hit model in newly diagnosed multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.108339","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"108339"}}